NEK2 and nonpapillary renal cell carcinoma: Therefore, we performed survival analysis in the TCGA cohort and found that NEK2 overexpression affects ccRCC patients’ poor overall survival (OS), disease-specific survival and progression-free interval (Fig. 2D–F).